Olomorasib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Olomorasib, covering 2025-09-22 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer [Phase 3]